| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 12388 |
| 1 | ACETAMINOPHEN | 6612 |
| 2 | PREDNISONE | 5864 |
| 3 | DIPHENHYDRAMINE HYDROCHLORIDE | 5800 |
| 4 | RITUXIMAB | 5752 |
| 5 | METHOTREXATE SODIUM | 5604 |
| 6 | METHOTREXATE | 5399 |
| 7 | ACETAMINOPHEN EXTRA STRENGTH | 4925 |
| 8 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 4925 |
| 9 | ACETAMINOPHEN, | 4925 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 151 | 0.6240 |
| 1 | PSEUDOEPHEDRINE HCL | 1270 | 0.3117 |
| 2 | CORTISONE ACETATE | 1465 | 0.2597 |
| 3 | CETIRIZINE HCL, PSEUDOEPHEDRINE HCL | 108 | 0.2571 |
| 4 | DESOXIMETASONE | 1910 | 0.2557 |
| 5 | CASIRIVIMAB AND IMDEVIMAB | 263 | 0.2325 |
| 6 | CAFFEINE CITRATE | 166 | 0.2213 |
| 7 | ETESEVIMAB | 190 | 0.1843 |
| 8 | PEGLOTICASE | 239 | 0.1573 |
| 9 | RHO (D) IMMUNE GLOBULIN | 49 | 0.1536 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 13011 |
| 1 | Corticosteroid [EPC] | 10371 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7282 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 7270 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 5581 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 5394 |
| 6 | Methylxanthine [EPC] | 5025 |
| 7 | Central Nervous System Stimulant [EPC] | 5011 |
| 8 | Vitamin B12 [EPC] | 4143 |
| 9 | Vitamin C [EPC] | 4067 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Uric Acid-specific Enzyme [EPC] | 239 | 0.1554 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 1750 | 0.0850 |
| 2 | Lysosomal beta Glucuronidase [EPC] | 2 | 0.0588 |
| 3 | Lipoglycopeptide Antibacterial [EPC] | 41 | 0.0562 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 3971 | 0.0525 |
| 5 | Human Immunoglobulin G [EPC] | 170 | 0.0488 |
| 6 | Chemokine Receptor Type 4 Interaction [EPC] | 31 | 0.0481 |
| 7 | Angiopoietin-like 3 Inhibitor [EPC] | 1 | 0.0476 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 7270 | 0.0468 |
| 9 | CD33-directed Immunoconjugate [EPC] | 121 | 0.0418 |